Butyrate promotes the antiviral effect of IFN when the encephalomyocarditis (EMC) virus infects MSV cells, while, butyrate protects against more severe disease caused by viral infection in vivo (Pouillart et al., 1992). This evidence concerns the gene IFNA1 and viral infectious disease.